Lipodystrophy: results of a data evaluation of patients receiving nelfinavir-containing combination therapy.
Lewis
R H
RH
Popescu
M
M
D019380:Anti-HIV Agents / Q000627:therapeutic use; D016208:Databases, Factual; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008060:Lipodystrophy / Q000453:epidemiology*; D019888:Nelfinavir / Q000009:adverse effects*; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019888:Nelfinavir